Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco
Patients with resectable non–small cell lung cancer (NSCLC) often receive treatment before they undergo surgery. For such patients who achieve a pathologic complete response (pCR), the chances of
Timing could make a difference: new results suggest that patients with glioblastoma who took temozolomide (Temodar) in the morning rather than the evening showed an improved overall survival.
Invasive lobular carcinoma (ILC) is a type of breast cancer that begins in the milk-producing glands (lobules) of the breast. It covers 10-15% of all breast cancer cases,
In people with central nervous system (CNS) lymphoma, cancerous B cells–a type of white blood cell–accumulate to form tumors in the brain or spinal cord, often in close
Singing may be the next-generation, noninvasive approach to determining the health of a patient’s thyroid. Typically, a fine needle is used to detect the presence of a tumor
Tumor cells constantly interact with the cellular environment they live in, affecting tumor progression and metastasis. In a new study, researchers from Tokyo Medical and Dental University (TMDU)
First proof: genetics affects cancer The genetics that will get a man in the cradle, determines in part, how high the risk is, the certain future of cancer
A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may predict recurrence of non-functional pancreatic neuroendocrine tumors (pNETs), which do not
A cardiac tumor is rare but dangerous Although heart diseases are for the most deaths, and cancer is the second, heart cancer is a very rare and little
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
